Table 4.

KEGG pathways significantly enriched in high and low-risk groups

Name	Size	ES	NES	NOM	FDR	FWER
				P-val	P-val	P-val
KEGG_NITROGEN_METABOLISM	23	0.497	1.539	0.037	0.470	0.8
KEGG_LINOLEIC_ACID_METABOL ISM	29	0.573	1.572	0.044	0.745	0.753
KEGG_PEROXISOME	78	− 0.483	− 1.871	0.002	0.151	0.176
KEGG_CHEMOKINE_SIGNALING_ PATHWAY	185	− 0.443	− 1.785	0.006	0.144	0.32
KEGG_FC_GAMMA_R_MEDIATED_GOCYTOSIS	95	− 0.479	− 1.821	0.006	0.119	0.244
KEGG_LEUKOCYTE_TRANSENDO THELIAL_MIGRATION	115	− 0.475	− 1.850	0.008	0.109	0.195
KEGG_PATHOGENIC_ESCHERICHI A_COLI_INFECTION	55	− 0.521	− 1.883	0.010	0.200	0.162
KEGG_LYSOSOME	119	− 0.568	− 1.956	0.010	0.167	0.081
KEGG_LEISHMANIA_INFECTION	69	− 0.608	− 1.866	0.012	0.118	0.178
KEGG_VIRAL_MYOCARDITIS	68	− 0.557	− 1.757	0.012	0.166	0.384
KEGG_ENDOCYTOSIS	178	− 0.378	− 1.581	0.017	0.317	0.729
KEGG_SNARE_INTERACTIONS_INICULAR_TRANSPORT	38	− 0.496	− 1.630	0.022	0.295	0.631
KEGG_GLUTATHIONE_METABOLI SM	48	− 0.455	− 1.648	0.025	0.283	0.605
KEGG_TOLL_LIKE_RECEPTOR_SI GNALING_PATHWAY	101	− 0.411	− 1.567	0.032	0.329	0.752
KEGG_ANTIGEN_PROCESSING_A ND_PRESENTATION	79	− 0.518	− 1.661	0.033	0.282	0.575
KEGG_COMPLEMENT_AND_COAG ULATION_CASCADES	69	− 0.457	− 1.590	0.037	0.318	0.715
KEGG_B_CELL_RECEPTOR_SIGNA LING_PATHWAY	74	− 0.427	− 1.591	0.037	0.339	0.714
KEGG_NOD_LIKE_RECEPTOR_SIG NALING_PATHWAY	61	− 0.454	− 1.598	0.037	0.351	0.703
G_ACUTE_MYELOID_LEUKEMA	57	− 0.445	− 1.548	0.041	0.316	0.782